AZZ three-lens brief
Evidence-based stock research on AZZ. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $162.30 — 22% above current (10 analysts).
AZZ closed at $132.49 (+1.28%) as of 2026-11-12. Market cap: $3.96B. P/E (trailing) 23.9. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $162.30 — 22% above current (10 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $486.89M, net income $58.45M, free cash flow $160.81M.
Why three lenses on AZZ, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AZZ across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AZZ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AZZ brief"></iframe>